In the not-so-distant past, physician prescribing data was essentially a commodity with limited breadth or depth for…

This past December, the FDA finalized its guidance on rare diseases with the publication Rare Diseases: Considerations…

Commercializing a pharmaceutical asset in one country is hard enough. Doing it on a global scale, with multiple country…

I grew up in the Midwest — the middle child in a large family. We were each tagged with certain labels and…

In this post-COVID era, our clients have experienced a culture shift — driven by remote work, digital transformation,…

Every horse race has a starting bell, a push to move as fast as possible, and a finish line. In many ways, the launch…

Over the past 20 years, The NemetzGroup has been involved in the launch of more than 50 different drugs and has had…

There are many ways we introduce ourselves to make an impact and grab the attention of our audience. In our line of…

“Gen Z professionals have a low tolerance for inefficiency and are not going to allow their boomer bosses to remain…

When it comes to team performance and adherence to “best practices,” what works on paper or in a teambuilding workshop…